GSK momelotinib receives US FDA acceptance for New Drug Application

GSK momelotinib receives US FDA acceptance for New Drug Application

Related Keywords

United States ,American , ,American Society Of Clinical Oncology Annual Meeting ,Sierra Oncology Inc ,European Hematology Association ,Drug Administration ,New Drug Application ,Prescription Drug User Fee Act ,Total Symptom Score ,Transfusion Independence ,Splenic Response Rate ,Clinical Oncology Annual Meeting ,Myelofibrosis Symptom Assessment ,Sierra Oncology ,